Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab

Abstract Background Morbidity and mortality are higher in immunocompromised patients affected by COVID-19 than in the general population. Some authors have successfully used antiviral combination, but never in the early phase of the infection. Methods We conducted a retrospective cohort study to det...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ivan Gentile, Maria Foggia, Maria Silvitelli, Alessia Sardanelli, Letizia Cattaneo, Giulio Viceconte
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2023-12-01
Edice:	Virology Journal
Témata:	COVID-19 Immunocompromised Sotrovimab Remdesivir Nirmatrelvir
On-line přístup:	https://doi.org/10.1186/s12985-023-02269-8
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!